Jump Financial LLC Boosts Stake in Merit Medical Systems, Inc. (NASDAQ:MMSI)

Jump Financial LLC grew its stake in Merit Medical Systems, Inc. (NASDAQ:MMSI) by 391.6% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 32,429 shares of the medical instruments supplier’s stock after acquiring an additional 25,833 shares during the quarter. Jump Financial LLC’s holdings in Merit Medical Systems were worth $3,137,000 at the end of the most recent quarter.

Several other large investors have also recently made changes to their positions in MMSI. Walleye Trading LLC bought a new stake in Merit Medical Systems during the fourth quarter valued at about $445,000. Walleye Capital LLC purchased a new stake in shares of Merit Medical Systems during the fourth quarter valued at about $499,000. CreativeOne Wealth LLC boosted its holdings in shares of Merit Medical Systems by 190.1% in the 4th quarter. CreativeOne Wealth LLC now owns 15,433 shares of the medical instruments supplier’s stock valued at $1,493,000 after buying an additional 10,113 shares in the last quarter. Summit Investment Advisors Inc. grew its position in shares of Merit Medical Systems by 3.3% in the 4th quarter. Summit Investment Advisors Inc. now owns 5,987 shares of the medical instruments supplier’s stock worth $579,000 after buying an additional 190 shares during the last quarter. Finally, Townsquare Capital LLC raised its stake in shares of Merit Medical Systems by 18.6% during the 4th quarter. Townsquare Capital LLC now owns 33,907 shares of the medical instruments supplier’s stock worth $3,279,000 after acquiring an additional 5,326 shares in the last quarter. 99.66% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several equities analysts have issued reports on the stock. Piper Sandler reaffirmed an “overweight” rating and issued a $116.00 price target (up from $114.00) on shares of Merit Medical Systems in a report on Wednesday, January 29th. Barrington Research restated an “outperform” rating and set a $111.00 target price on shares of Merit Medical Systems in a research note on Friday, April 11th. Raymond James increased their price target on Merit Medical Systems from $105.00 to $110.00 and gave the company an “outperform” rating in a research note on Tuesday, December 31st. Needham & Company LLC restated a “buy” rating and set a $116.00 price target on shares of Merit Medical Systems in a research note on Wednesday, April 9th. Finally, Canaccord Genuity Group decreased their price objective on shares of Merit Medical Systems from $128.00 to $127.00 and set a “buy” rating for the company in a research report on Wednesday, February 26th. Two analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat, Merit Medical Systems has an average rating of “Moderate Buy” and an average price target of $114.33.

Merit Medical Systems Stock Performance

MMSI opened at $90.89 on Friday. The company has a current ratio of 5.36, a quick ratio of 3.82 and a debt-to-equity ratio of 0.57. Merit Medical Systems, Inc. has a 12-month low of $70.70 and a 12-month high of $111.45. The firm has a 50 day moving average of $100.51 and a two-hundred day moving average of $100.66. The firm has a market capitalization of $5.37 billion, a PE ratio of 44.55, a P/E/G ratio of 2.34 and a beta of 0.85.

Insider Transactions at Merit Medical Systems

In other news, CEO Fred P. Lampropoulos sold 31,320 shares of the company’s stock in a transaction dated Wednesday, March 5th. The stock was sold at an average price of $103.86, for a total value of $3,252,895.20. Following the sale, the chief executive officer now owns 1,086,028 shares in the company, valued at $112,794,868.08. This represents a 2.80 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Brian G. Lloyd sold 30,000 shares of Merit Medical Systems stock in a transaction that occurred on Wednesday, March 5th. The shares were sold at an average price of $102.90, for a total value of $3,087,000.00. Following the transaction, the insider now owns 38,945 shares of the company’s stock, valued at approximately $4,007,440.50. This represents a 43.51 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 109,132 shares of company stock worth $11,139,521 over the last 90 days. 3.70% of the stock is currently owned by company insiders.

Merit Medical Systems Profile

Merit Medical Systems, Inc designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions.